| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.07 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |